Clinical Trial: Proof of Concept Study of Gevokizumab in the Treatment of Pyoderma Gangrenosum

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: An Open-label, Proof of Concept Study of Gevokizumab in the Treatment of the Acute, Inflammatory Phase of Pyoderma Gangrenosum

Brief Summary: The study will evaluate the safety and biologic activity of gevokizumab in subjects in the acute inflammatory phase of pyoderma gangrenosum.